Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk
- PMID: 36119100
- PMCID: PMC9472241
- DOI: 10.3389/fimmu.2022.1018384
Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk
Abstract
[This corrects the article DOI: 10.3389/fimmu.2022.873067.].
Keywords: BCG; COVID-19; SARS-CoV-2; elderly vaccination; trained immunity.
Copyright © 2022 Tsilika, Taks, Dolianitis, Kotsaki, Leventogiannis, Damoulari, Kostoula, Paneta, Adamis, Papanikolaou, Stamatelopoulos, Bolanou, Katsaros, Delavinia, Perdios, Pandi, Tsiakos, Proios, Kalogianni, Delis, Skliros, Akinosoglou, Perdikouli, Poulakou, Milionis, Athanassopoulou, Kalpaki, Efstratiou, Perraki, Papadopoulos, Netea and Giamarellos-Bourboulis.
Erratum for
-
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.Front Immunol. 2022 Jul 5;13:873067. doi: 10.3389/fimmu.2022.873067. eCollection 2022. Front Immunol. 2022. PMID: 35865520 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous